Method and device for administering xenon to patients

Details for Australian Patent Application No. 2005226926 (hide)

Owner INO Therapeutics GmbH

Inventors Mullner, Rainer

Agent Davies Collison Cave

Pub. Number AU-A-2005226926

PCT Pub. Number WO2005/092417

Priority 10 2004 015 406.6 26.03.04 DE

Filing date 24 March 2005

Wipo publication date 6 October 2005

International Classifications

A61M 1/36 (2006.01) Suction or pumping devices for medical purposes - Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation

A61M 16/10 (2006.01) Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration - Preparation of respiratory gases or vapours

Event Publications

9 November 2006 PCT application entered the National Phase

  PCT publication WO2005/092417 Priority application(s): WO2005/092417

19 April 2007 Assignment before Grant

  INO Therapeutics GmbH The application has been assigned to Air Products and Chemicals, Inc.

12 March 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005226927-Gastroresistant pharmaceutical dosage form comprising N- (2-(2-phthalimidoethoxy)-acetyl)-L-alan yl-D-glutamic acid (LK-423)

2005226925-Uses of galectin-2